While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SGCCTL-COP-pRSGCCG
$300.00
sgRNA targeting the copGFP fluorescent protein in a Cas9 CRISPR vector. Usually used as a CRISPR negative control, but can be used as a positive control if cells have been engineered to express copGFP. Lentiviral copGFP expression construct is available separate from Cellecta.